Angiodynamics (ANGO) EBIT Growth (1y) (2011 - 2026)
Angiodynamics (ANGO) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.31 Bn | 129.09 Bn | 1.96 Bn | 30.74% |
| 2 | Becton Dickinson | 52.51 Bn | 51.64 Bn | 2.32 Bn | -10.28% |
| 3 | Alcon | 35.75 Bn | 34.40 Bn | 1.68 Bn | -95.55% |
| 4 | Resmed | 33.70 Bn | 32.23 Bn | 861.22 Mn | -1.28% |
| 5 | Medline | 29.09 Bn | 26.41 Bn | 2.22 Bn | -38.47% |
| 6 | West Pharmaceutical Services | 25.03 Bn | 24.60 Bn | 329.20 Mn | 16.53% |
| 7 | Solventum | 15.40 Bn | 14.99 Bn | 1.29 Bn | -15.42% |
| 8 | Cooper Companies | 14.81 Bn | 14.68 Bn | 735.40 Mn | -116.77% |
| 9 | Baxter International | 13.57 Bn | 11.42 Bn | 1.03 Bn | 13.61% |
| 10 | Angiodynamics | 654.03 Mn | 600.17 Mn | 46.77 Mn | -76.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -76.14% |
| Feb 28, 2026 | -29.85% |
| Nov 30, 2025 | 44.79% |
| Aug 31, 2025 | 18.64% |
| May 31, 2025 | 59.94% |
| Feb 28, 2025 | 95.01% |
| Nov 30, 2024 | 15.44% |
| Aug 31, 2024 | -137.39% |
| May 31, 2024 | 30.66% |
| Feb 29, 2024 | -2,138.98% |
| Nov 30, 2023 | -61.68% |
| Aug 31, 2023 | 363.36% |
| May 31, 2023 | -225.73% |
| Feb 28, 2023 | -68.61% |
| Nov 30, 2022 | 6.50% |
| Aug 31, 2022 | -64.21% |
| May 31, 2022 | 70.37% |
| Feb 28, 2022 | -41.65% |
| Nov 30, 2021 | -79.47% |
| Aug 31, 2021 | -58.14% |